PAROLARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 11.906
EU - Europa 7.659
AS - Asia 1.434
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 7
AF - Africa 4
Totale 21.042
Nazione #
US - Stati Uniti d'America 11.867
IT - Italia 3.974
UA - Ucraina 1.450
SE - Svezia 760
TR - Turchia 613
VN - Vietnam 421
IE - Irlanda 396
CN - Cina 360
FI - Finlandia 352
DE - Germania 293
GB - Regno Unito 205
FR - Francia 100
BE - Belgio 63
CA - Canada 36
EU - Europa 15
IN - India 13
NL - Olanda 12
ES - Italia 7
BG - Bulgaria 6
BR - Brasile 6
RU - Federazione Russa 6
AU - Australia 5
CL - Cile 5
DK - Danimarca 5
PT - Portogallo 5
CH - Svizzera 4
JP - Giappone 4
PK - Pakistan 4
CO - Colombia 3
HU - Ungheria 3
MY - Malesia 3
SG - Singapore 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
GR - Grecia 2
IL - Israele 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MX - Messico 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
AL - Albania 1
AT - Austria 1
BT - Bhutan 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
HK - Hong Kong 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 21.042
Città #
Milan 2.817
Fairfield 1.834
Woodbridge 1.128
Jacksonville 1.099
Chandler 1.089
Ashburn 877
Houston 828
Seattle 750
Wilmington 728
Ann Arbor 659
Cambridge 607
Dublin 395
Dearborn 393
Princeton 380
Izmir 352
Nyköping 349
Rome 223
Dong Ket 218
Como 190
San Mateo 161
San Diego 88
Beijing 69
Brussels 63
Washington 59
Hefei 48
Kunming 42
Norwalk 38
London 35
Nanjing 34
Toronto 27
Ponte Lambro 23
Boardman 21
Nanchang 19
Verona 19
Guangzhou 18
Mcallen 18
Redwood City 18
Kocaeli 17
Berlin 16
Düsseldorf 16
Fuzhou 14
Falls Church 13
Jinan 13
Carbonara Al Ticino 12
Edinburgh 12
Chicago 11
Cagliari 10
Helsinki 9
Frankfurt am Main 8
Ottawa 8
Redmond 8
Shenyang 8
Varese 8
Benevento 7
Bologna 7
Chengdu 7
New York 7
Wuhan 7
Amritsar 6
Ankara 6
Istanbul 6
Prescot 6
Sofia 6
Zhengzhou 6
Auburn Hills 5
Chongqing 5
Lisbon 5
Amsterdam 4
Bollate 4
Cairate 4
Chiswick 4
Copenhagen 4
Hebei 4
Hounslow 4
Islamabad 4
Los Angeles 4
Madrid 4
Naples 4
Napoli 4
Phoenix 4
San Giuliano Milanese 4
Shanghai 4
Stuttgart 4
Villanovafranca 4
Boydton 3
Budapest 3
Changsha 3
Indiana 3
Jinhua 3
Kuala Lumpur 3
Manchester 3
Melbourne 3
Miami 3
Moscow 3
New Bedfont 3
Paris 3
Pune 3
Salerno 3
Siena 3
Simi Valley 3
Totale 16.101
Nome #
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 240
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 216
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 213
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 195
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 194
Assay of GTPγS binding in autoradiography 189
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 188
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 188
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 186
Long lasting consequences of cannabis exposure in adolescence. 185
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 185
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 182
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 180
New vistas on cannabis use disorder 179
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 178
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 176
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 176
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 173
A molecular basis of analgesic tolerance to cannabinoids 171
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 169
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 167
Cannabinoids and opioids share cAMP pathway in rat splenocytes 165
MeCP2 related studies benefit from the use of CD1 as genetic background 163
Endocannabinoids and Mental Disorders. 162
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 158
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat 155
Role of endocannabinoids in regulating drug dependence 155
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 152
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 152
Expression and function of the endocannabinoid system in glial cells. 151
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 149
Cannabinoids and Drugs of abuse 149
The endocannabinoid system and schizophrenia: integration of evidence. 147
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 147
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 146
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 145
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 144
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 144
Molecular and cellular basis of cannabinoid and opioid interactions 142
Sex-dependent vulnerability to cannabis abuse in adolescence 142
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 141
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 141
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 140
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor. 137
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi 136
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 135
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 135
Endocannabinoids and Drug Dependence 135
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche 132
null 132
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 131
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 130
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw 130
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 130
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 130
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 130
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system 129
Cannabidiol inhibits angiogenesis by multiple mechanisms 129
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 128
The endocannabinoid system and psychiatric disorders. 128
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 127
The psychoactive ingredient of marijuana induces behavioural sensitization 126
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat 126
Binding studies of dermorphin and its L-form on rat brain opioid receptors. 126
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects 126
Endocannabinoids in the immune system and cancer 125
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 125
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 124
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats. 123
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 122
Cholera toxin effects on body temperature changes induced by morphine. 122
Presence and functional regulation of cannabinoid receptors in immune cells 121
Pertussis toxin inhibits the antinociceptive action of morphine in the rat.. 121
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 118
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 118
A role of nitric oxide in WIN 55,212-2 tolerance in mice. 118
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 116
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors 116
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 116
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. 116
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 116
Cannabinoids as potential new therapy for the treatment of gliomas. 115
Presence of a reduced opioid response in interleukin-6 knock out mice 115
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. 115
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 115
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 115
Cannabinoids, immune system and cytokine network 114
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine.. 113
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system 112
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells 112
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 111
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine. 111
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. 111
Neurobiological mechanisms underlying cannabis-induced memory impairment 110
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 109
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 109
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 108
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. 107
Intestinal effect and analgesia: evidence for different involvement of opioid receptor subtypes in periaqueductal gray matter. 106
Is cannabinoid transmission involved in rewarding properties of drugs of abuse 105
Totale 14.118
Categoria #
all - tutte 52.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.921 0 0 0 0 0 24 50 200 34 243 561 809
2019/20204.773 223 181 215 994 331 536 665 586 362 326 79 275
2020/20213.189 80 340 132 300 192 343 143 248 470 168 295 478
2021/20221.930 192 203 182 251 58 89 71 94 94 282 149 265
2022/20232.758 265 165 192 326 157 582 14 381 405 89 126 56
2023/20244.105 722 747 728 848 927 133 0 0 0 0 0 0
Totale 21.171